Searchable abstracts of presentations at key conferences in endocrinology

ea0032p23 | Adrenal cortex | ECE2013

Immunohistochemical markers of adrenal cortical tumors

Altieri Barbara , Fadda Guido , Capozzi Anna , Pontecorvi Alfredo , Casa Silvia Della

Introduction: Adrenocortical tumors (ACTs) are usually divided in adenoma (ACA) or carcinoma (ACC) according to histopathologic methods. Some lesions are occasionally difficult to classify according to these criteria. We studied the use of some immunohistochemical markers to recognise the difference between malignant and benign tumors.Materials and methods: We studied 12 patients affected by ACC and 10 by ACA. Clinical evaluation and hormone analysis wer...

ea0022p40 | Adrenal | ECE2010

Higher cortisol response to glucose load in patient with adrenal adenomas and subclinical Cushing (SC)

Vicennati Valentina , di Dalmazi Guido , Casadio Elena , Repaci Andrea , Pagotto Uberto , Pasquali Renato

Aims: SC can be discovered in 5–20% of the incidentalomas. Subclinical secretion is defined by the failure to suppress plasma cortisol after 1 mg-overnight dexamethasone <50 nmol/l, but there is no agreement in literature. The aim of our study was to evaluate cortisol response to oral glucose tolerance test (OGTT) as potential marker of autonomous activity of these adenomas.Methods: Ninety subjects, 47 females and 43 males, underwent the protoco...

ea0022p426 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Adrenocortical carcinoma (ACC): our experience

Di Dalmazi Guido , Ripani Raffaella , Casadio Elena , Vicennati Valentina , Pagotto Uberto , Pasquali Renato

Aim: ACC is an extremely rare heterogeneous aggressive disease. Clinical presentation are various. The prognosis is very poor. There are limited data to define prognostic markers for survival beyond stage.The aim of this study is to describe the experience of our institution with patients affected by ACC.Material and methods: This study was performed on 13 patients aged between 26 and 76 years, from 1992 to 2009 who turned to our I...

ea0020p252 | Bone/Calcium | ECE2009

Metabolic and cardiovascular risk in primary hyperparathyroidism

Dolcino Mara , Massaro Francesca , Vera Lara , Oddo Silvia , Rodriguez Guido , Ferone Diego , Minuto Francesco , Giusti Massimo

Background: Primary hyperparathyroidism (PHP) is associated with increased rates of cardiovascular (CV) risk. Moreover, it is not fully clear whether surgery can attenuate CV risk. The intima-media thickness (IMT) of carotid vessels is considered a marker of atherosclerosis and CV events.Aim: Of the study was to evaluate IMT and some metabolic parameters in PHP patients.Subjects: Of 56 subjects were studied. Patients were divided i...

ea0020p657 | Reproduction | ECE2009

Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with PCO syndrome

Masha Andi , Manieri Chiara , Dinatale Stefano , Bruno Guido Albino , Ghigo Ezio , Martina Valentino

Introduction: Nitric oxide (NO) plays a wide spectrum of biological actions including a positive role in oocyte maturation and ovulation. Free radicals have been shown elevated in PCOS and therefore would be responsible for quenching NO that, in turn, would play a role in determining oligo or amenorrhea connoting PCOS. We recently demonstrated that the combined administration of N-acetylcysteine (NAC) and arginine (ARG) is able to exert an antioxidant action leading to ...

ea0015s25 | Androgen receptors - physiology and disease | SFEBES2008

Tissue-specific androgen receptor knockout models. novel tools in the study of androgen action

Verhoeven Guido , Denolet Evi , Swinnen Johannes , Saunders Philippa , Sharpe Richard , De Gendt Karel

Specific ablation of the androgen receptor (AR) in selected target cells prevents the major developmental defects inherent to generalised AR inactivation (Tfm, ARKO) and allows a detailed analysis of the contribution of defined cells and molecular pathways to more complex effects of androgens. We successfully applied this approach in the study of the role of androgens in the control of spermatogenesis, by developing a Cre/loxP-based mouse model with a Sertoli cell (SC)-selecti...

ea0014s23.1 | Reproductive endocrinology/andrology | ECE2007

Androgen regulation of spermatogenesis

Saunders Philippa , Smtih Lee , Hooley Robert , De Gendt Karel , Denolet Evi , Verhoeven Guido , Sharpe Richard

Spermatogenesis is a complex process involving interactions between the somatic cells (Sertoli, Leydig, peritubular) and germ cells within the adult testis. Androgens are key regulators of spermatogenesis and intra-testicular concentrations of testosterone (T), produced by the Leydig cells, are higher than that in blood. Androgen action is mediated by the androgen receptor (AR), an X-chromosome-encoded, ligand-activated, transcription factor. The mechanisms by which androgens ...

ea0014p323 | (1) | ECE2007

Thyroid abnormalities during treatment with PEGIFNα-2a and PEGIFNα-2b in patients affected by HCV-related chronic disease: &br;a prospective randomized study

Scavuzzo Francesco , Monda Guido Di , Serino Domenico , Tartaglione Maria Teresa , Lampasi Filippo , Ascione Antonio , Volpe Raffaele

Background: Correlation between therapy with interferons, thyroid autoimmunity and dysfunction is widely reported. Currently we used two different pegilated-interferons (α-2a, α-2b).Aim: Evaluate a probable different behaviour of two PEG-IFN responsible of thyroid abnormalities.Patients and methods: We observed 236 consecutive naïve-patients with HCV-related chronic-disease undergoing a treatment with antiviral thera...

ea0056p441 | Diabetes complications | ECE2018

Impaired awareness of hypoglycaemia does not affect the prevalence of diabetes-related distress in people with diabetes type 1

Tsitlakidis Damianos , Kuniss Nadine , Alfons Muller Ulrich , Muller Nicolle , Kloos Christof , Kramer Guido

Objective: The aim of this study was to assess prevalence of impaired awareness of hypoglycaemia (IAH) by the Gold method in people with type 1 diabetes and to compare people with and with IAH regarding metabolic control.Methods: In a cross-sectional study, we assessed IAH in 139 people with type 1 diabetes (54.1y, diabetes duration 24.0y, HbA1c 7.1%) attending the University outpatient department for endocrinology and metabolic diseases. IAH was assesse...

ea0081p29 | Adrenal and Cardiovascular Endocrinology | ECE2022

The changing face of drug-induced adrenal insufficiency in the food and drug administration adverse event reporting system

Raschi Emanuel , Fusaroli Michele , Massari Francesco , Mollica Veronica , Repaci Andrea , Ardizzoni Andrea , Poluzzi Elisabetta , Pagotto Uberto , Di Dalmazi Guido

Importance: Adrenal insufficiency is a life-threatening condition complicating heterogenous disorders across various disciplines, with challenging diagnosis and a notable drug-induced component.Objective: To describe the spectrum and main features of drug-induced adrenal insufficiency through adverse drug event reports received by the Food and Drug Administration (FDA).Design: We conducted a retrospective disproportionality analysi...